Skip to main content
SPRC logo

SciSparc Ltd.

SPRCNASDAQHealthcareBiotechnology

$2.00Today:- (-)1Y −49.11%

As of Oct 15, 2026 close

Market cap
$1.11M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.55$18.14
Volume (live)
-
Avg. volume (3M)
1.18M

SciSparc (SPRC) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), SciSparc used $4.14M of cash in operating activities. Free cash flow was −$4.14M.

SciSparc Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for SciSparc Ltd. (SPRC) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-12.56-7.47-5.12-2.59-5.79-3.54-4.69-8.95-6.24
Depreciation & Amortization0.230.480.540.190.030.160.180.150.01
Deferred Income Tax0.000.000.000.000.000.801.22-0.060.00
Stock Based Compensation1.190.570.200.900.040.090.550.600.86
Change in Working Capital1.450.14-0.83-0.700.64-1.35-2.121.400.27
Change in Accounts Receivable0.790.01-0.35-0.080.17-0.520.33-0.10-0.14
Change in Inventory0.040.63-0.07-0.67-0.170.52-0.330.650.00
Change in Accounts Payable-0.160.03-0.400.040.35-0.75-0.840.180.35
Change in Other Working Capital0.78-0.55-0.010.000.29-0.59-1.280.670.07
Other Operating Activities5.561.18-0.67-5.710.01-0.480.16-0.270.53
Net Cash from Operating Activities-4.14-5.10-5.89-7.92-5.06-4.31-4.70-7.13-4.58
Investing Activities
Capital Expenditures0.000.000.00-0.01-0.040.000.00-0.02-0.04
Acquisitions0.60-0.602.59-0.700.000.000.720.010.00
Purchases of Investments0.00-0.60-3.69-2.200.000.000.00-0.010.00
Sales/Maturities of Investments0.003.000.00-4.860.000.02-0.720.010.00
Other Investing Activities-2.00-1.030.00-0.02-0.040.021.27-2.09-0.01
Net Cash from Investing Activities-1.40-1.63-1.11-7.08-0.070.021.27-2.09-0.05
Financing Activities
Debt Repayment4.50-0.05-0.05-0.07-0.210.22-0.051.570.00
Common Stock Issued4.096.265.5511.787.702.652.220.0013.19
Other Financing Activities0.00-0.01-0.010.002.552.490.64-0.04-0.02
Net Cash from Financing Activities8.596.195.5011.7010.065.362.801.5413.18
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.01-0.02-0.53
Net Change in Cash3.05-0.54-1.50-3.304.931.08-0.62-7.718.52
Cash at Beginning of Period1.542.083.576.881.950.871.499.200.68
Cash at End of Period4.591.542.083.576.881.950.871.499.20
Free Cash Flow-4.14-5.10-5.89-7.93-5.10-4.31-4.70-7.15-4.62
Supplemental Disclosures
Interest Paid-0.010.010.01-0.01---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About SciSparc Cash Flow

What is SciSparc's free cash flow?

SciSparc had negative free cash flow of $4.14M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does SciSparc pay dividends or buy back shares?

SciSparc's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition